You searched for side effects - Page 100 of 311 - Medivizor
Navigation Menu

Evaluating brentuximab vedotin for elderly patients with hard to treat Hodgkin lymphoma

Evaluating brentuximab vedotin for elderly patients with hard to treat Hodgkin lymphoma

Posted by on Mar 24, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of brentuximab vedotin (Adcetris) in elderly patients with relapsed or unresponsive Hodgkin lymphoma (HL). This study found that this treatment was effective, although frail patients may be at higher risk for side effects. Some background Most patients with HL respond to front-line...

Read More

Risk adjusted treatment of children with non-T cell acute lymphoblastic leukemia

Risk adjusted treatment of children with non-T cell acute lymphoblastic leukemia

Posted by on Mar 24, 2020 in Leukemia | 0 comments

In a nutshell The study reported the outcomes of children with non-T cell acute lymphoblastic leukemia (ALL) treated with risk-adjusted therapy. The main finding was that patients with standard-risk (SR) ALL had improved survival without cancer-related events. Some background ALL-97 was the first clinical trial performed on Japanese children with ALL....

Read More

High-intensity exercise rehabilitation improves sleep disorder outcomes in patients with Parkinson’s disease

High-intensity exercise rehabilitation improves sleep disorder outcomes in patients with Parkinson’s disease

Posted by on Mar 20, 2020 in Parkinson's Disease | 0 comments

In a nutshell This study investigated whether high-intensity exercise rehabilitation (HIER) improved sleep in patients with Parkinson's disease (PD). Researchers suggested that HIER improves sleep in these patients. Some background Parkinson's disease (PD) is a progressive brain disorder. The brain cells lose their abilities to control...

Read More

Evaluating bortezomib consolidation or maintenance for patients with multiple myeloma

Evaluating bortezomib consolidation or maintenance for patients with multiple myeloma

Posted by on Mar 19, 2020 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of consolidation and maintenance regimens containing bortezomib (Velcade) for multiple myeloma (MM). This study concluded that consolidation therapy with bortezomib improved survival without tumor growth or spread. Some background Multiple myeloma is a type of cancer of the bone...

Read More

Reviewing treatment options for patients with high-risk prostate cancer

Reviewing treatment options for patients with high-risk prostate cancer

Posted by on Mar 19, 2020 in Prostate cancer | 0 comments

In a nutshell This article reviewed treatment options for patients with high-risk prostate cancer. Some background Prostate cancer is a cancer that starts in the prostate gland. There are different types of treatment for patients with prostate cancer. Treatment choice depends on disease stage or whether the cancer has spread to other parts of the...

Read More

Is tamsulosin and tadalafil a safe and effective treatment for lower urinary tract symptoms?

Is tamsulosin and tadalafil a safe and effective treatment for lower urinary tract symptoms?

Posted by on Mar 13, 2020 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study aimed to compare the effectiveness and safety of tamsulosin (Flomax) versus tamsulosin and tadalafil (Cialis) for the treatment of lower urinary tract symptoms (LUTS). The main finding was that the combination treatment appeared to improve LUTS more than treatment with tamsulosin alone, with no difference in side effects. Some...

Read More

Treating chronic myeloid leukemia with dasatinib

Treating chronic myeloid leukemia with dasatinib

Posted by on Mar 13, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the long-term outcomes of dasatinib treatment for patients with chronic myeloid leukemia.   This study concluded that dasatinib is safe and provides positive long-term outcomes for these patients.   Some background Dasatinib (Sprycel) is a targeted therapy...

Read More

Is mirabegron a safe and effective treatment for overactive bladder symptoms?

Is mirabegron a safe and effective treatment for overactive bladder symptoms?

Posted by on Mar 10, 2020 in Overactive bladder | 0 comments

In a nutshell This paper investigated the effectiveness and safety of mirabegron (Myrbetriq) for the treatment of symptoms of overactive bladder (OAB). Mirabegron appeared to be safe and effective for the treatment of OAB symptoms. Some background OAB is characterized by symptoms such as experiencing incontinence (urine leakage), having a strong urge...

Read More

Evaluating pembrolizumab plus R-CHOP chemotherapy for patients with untreated diffuse large B-cell lymphoma

Evaluating pembrolizumab plus R-CHOP chemotherapy for patients with untreated diffuse large B-cell lymphoma

Posted by on Mar 10, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of pembrolizumab (Keytruda) plus R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy for patients with diffuse large B-cell lymphoma (DLBCL). This study concluded that pembrolizumab can be safely added to R-CHOP, with improved survival outcomes. Some...

Read More